Gergely Imre

Protocol for cyclic DNA-damaging treatments to generate high mutational burden in the human A549 cell line

Here, we present a protocol that describes iterative exposure of the human lung cancer cell line A549 to DNA-damaging agents to progressively increase mutational burden. We describe steps for controlled cytotoxic dosing, metabolic activation, and repeated treatment cycles of up t...